231 related articles for article (PubMed ID: 35205315)
21. Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions.
Lavacchi D; Caliman E; Rossi G; Buttitta E; Botteri C; Fancelli S; Pellegrini E; Roviello G; Pillozzi S; Antonuzzo L
Pharmacol Ther; 2022 Sep; 237():108170. PubMed ID: 35296436
[TBL] [Abstract][Full Text] [Related]
22. MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients.
Cheng CT; Chen YY; Wu RC; Tsai CY; Chiang KC; Yeh TS; Chen MH; Yeh CN
Oncol Rep; 2018 Sep; 40(3):1411-1421. PubMed ID: 30015968
[TBL] [Abstract][Full Text] [Related]
23. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
[TBL] [Abstract][Full Text] [Related]
24. Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy.
O'Rourke CJ; Salati M; Rae C; Carpino G; Leslie H; Pea A; Prete MG; Bonetti LR; Amato F; Montal R; Upstill-Goddard R; Nixon C; Sanchon-Sanchez P; Kunderfranco P; Sia D; Gaudio E; Overi D; Cascinu S; Hogdall D; Pugh S; Domingo E; Primrose JN; Bridgewater J; Spallanzani A; Gelsomino F; Llovet JM; Calvisi DF; Boulter L; Caputo F; Lleo A; Jamieson NB; Luppi G; Dominici M; Andersen JB; Braconi C
Gut; 2024 Feb; 73(3):496-508. PubMed ID: 37758326
[TBL] [Abstract][Full Text] [Related]
25. Circular RNA CDR1as Exerts Oncogenic Properties Partially through Regulating MicroRNA 641 in Cholangiocarcinoma.
Li D; Tang Z; Gao Z; Shen P; Liu Z; Dang X
Mol Cell Biol; 2020 Jul; 40(15):. PubMed ID: 32423991
[TBL] [Abstract][Full Text] [Related]
26. Identification of a ferroptosis-related gene signature for predicting the prognosis of cholangiocarcinoma.
Wang Z; Zhang Y; Chen Y; Liu S; Li C; Li X
Expert Rev Gastroenterol Hepatol; 2022 Feb; 16(2):181-191. PubMed ID: 35026122
[TBL] [Abstract][Full Text] [Related]
27. Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma.
Zhou D; Gao B; Yang Q; Kong Y; Wang W
Biomed Res Int; 2019; 2019():2601271. PubMed ID: 31886187
[TBL] [Abstract][Full Text] [Related]
28. Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines.
Yang J; Sontag D; Gong Y; Minuk GY
Ann Hepatol; 2021; 21():100265. PubMed ID: 33045415
[TBL] [Abstract][Full Text] [Related]
29. Molecular therapeutic targets for cholangiocarcinoma: Present challenges and future possibilities.
Høgdall D; O'Rourke CJ; Andersen JB
Adv Cancer Res; 2022; 156():343-366. PubMed ID: 35961705
[TBL] [Abstract][Full Text] [Related]
30. Cholangiocarcinoma - novel biological insights and therapeutic strategies.
Ilyas SI; Affo S; Goyal L; Lamarca A; Sapisochin G; Yang JD; Gores GJ
Nat Rev Clin Oncol; 2023 Jul; 20(7):470-486. PubMed ID: 37188899
[TBL] [Abstract][Full Text] [Related]
31. Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance.
Fouassier L; Marzioni M; Afonso MB; Dooley S; Gaston K; Giannelli G; Rodrigues CMP; Lozano E; Mancarella S; Segatto O; Vaquero J; Marin JJG; Coulouarn C
Liver Int; 2019 May; 39 Suppl 1():43-62. PubMed ID: 30903728
[TBL] [Abstract][Full Text] [Related]
32. Annexin A1: A new immunohistological marker of cholangiocarcinoma.
Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S
World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846
[TBL] [Abstract][Full Text] [Related]
33. Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining.
Wang Z; Du Y
Int Immunopharmacol; 2021 Oct; 99():108039. PubMed ID: 34426102
[TBL] [Abstract][Full Text] [Related]
34. A Cholangiocarcinoma Prediction Model Based on Random Forest and Artificial Neural Network Algorithm.
Liao J; Meng C; Liu B; Zheng M; Qin J
J Coll Physicians Surg Pak; 2023 May; 33(5):578-586. PubMed ID: 37190696
[TBL] [Abstract][Full Text] [Related]
35. Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.
Jinawath A; Akiyama Y; Sripa B; Yuasa Y
J Cancer Res Clin Oncol; 2007 Apr; 133(4):271-8. PubMed ID: 17294242
[TBL] [Abstract][Full Text] [Related]
36. Practical considerations in screening for genetic alterations in cholangiocarcinoma.
Bekaii-Saab TS; Bridgewater J; Normanno N
Ann Oncol; 2021 Sep; 32(9):1111-1126. PubMed ID: 33932504
[TBL] [Abstract][Full Text] [Related]
37. Unveiling the immunogenomic landscape of cholangiocarcinoma: Identifying new prognostic markers and therapeutic targets based on CCL5 expression.
Wang J; Xiang D; Dai Z; Zhu J; Du Y; Fu G; Chu X
J Gene Med; 2024 Jan; 26(1):e3630. PubMed ID: 37985959
[TBL] [Abstract][Full Text] [Related]
38. Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies.
Hong JH; Yong CH; Heng HL; Chan JY; Lau MC; Chen J; Lee JY; Lim AH; Li Z; Guan P; Chu PL; Boot A; Ng SR; Yao X; Wee FYT; Lim JCT; Liu W; Wang P; Xiao R; Zeng X; Sun Y; Koh J; Kwek XY; Ng CCY; Klanrit P; Zhang Y; Lai J; Tai DWM; Pairojkul C; Dima S; Popescu I; Hsieh SY; Yu MC; Yeong J; Kongpetch S; Jusakul A; Loilome W; Tan P; Tan J; Teh BT
Gut; 2024 May; 73(6):966-984. PubMed ID: 38050079
[TBL] [Abstract][Full Text] [Related]
39. Over-expression of TNNI3K is associated with early-stage carcinogenesis of cholangiocarcinoma.
Yeh CN; Chen MH; Chang YC; Wu RC; Tsao LC; Wang SY; Cheng CT; Chiang KC; Chen TW; Hsiao M; Weng WH
Mol Carcinog; 2019 Feb; 58(2):270-278. PubMed ID: 30334579
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J
Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
